Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05155501 · ClinicalTrials.gov registry record · NA

Clinical Trial of Approaches to Prostate Cancer Surgery

A NA study of Prostate Cancer, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
5
Study locations

NCT05155501 is a NA study of Prostate Cancer that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 600 participants, roughly in line with the 607-participant average among 735 other Prostate Cancer trials with a reported enrollment target. The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05155501, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
5
Study locations

Study Summary

This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.

Conditions Studied

Prostate Cancer

Interventions

  • PROCEDURE Robot-assisted radical prostatectomy (RP)
  • PROCEDURE Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP)

Study Locations (5)

New York

  • NewYork-Presbyterian Queens - Flushing
  • Weill Cornell Medicine - New York

District of Columbia

  • Georgetown University - Washington D.C.

Illinois

  • Northwestern University - Chicago

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2023-05-15
Est. Completion 2026-12
Phase NA

Sponsor

Weill Medical College of Cornell University

701 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05155501

The ClinicalTrials.gov registry entry for NCT05155501 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 607-participant average among 735 other Prostate Cancer trials with a reported enrollment target. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Robot-assisted radical prostatectomy (RP) is the first listed.

NCT05155501 reports 5 study locations spanning 4 distinct geographic areas - top geographies include New York, District of Columbia, Illinois.

Frequently Asked Questions

What is clinical trial NCT05155501 about?

NCT05155501 is a clinical study titled "Clinical Trial of Approaches to Prostate Cancer Surgery". This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have simil...

What is the current status of trial NCT05155501?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2023-05-15. Estimated completion is 2026-12.

What conditions does trial NCT05155501 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05155501?

The interventions under investigation include: Robot-assisted radical prostatectomy (RP) (PROCEDURE), Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP) (PROCEDURE).

Who is sponsoring clinical trial NCT05155501?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05155501 being conducted?

This trial has 5 study locations across District of Columbia, Illinois, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.